The U.S. Food and Drug Administration approved the pill for weight loss earlier this month, intensifying Lilly's competition ...

Eli Lilly, the maker of the popular GLP-1 injectable Mounjaro, has invested heavily in Houston as a biotechnology hub.

The U.S. Food and Drug Administration is asking Eli Lilly and Company, the leading manufacturer of GLP-1s, for additional ...

Eli Lilly just released results of a clinical trial that may ease concerns about the safety of its new weight-loss pill ...

"Lilly debuts more Foundayo data as FDA requests post-marketing trials" was originally created and published by ...

D.C.’s celebration of its own Emancipation Day will be marked with a festival, parade and concert Sunday at 13th and ...

Eli Lilly’s late-stage study of the efficacy and safety of a treatment for type 2 diabetes has produced positive results.

Lilly plans to file Foundayo with the FDA for type 2 diabetes by end of Q2 after the ACHIEVE-4 trial met its primary ...

It's acquiring an asset with a very promising lead drug candidate.

April 16 () - Eli Lilly said on Thursday its newly approved obesity ‌pill helped reduce the risk ‌of major cardiovascular ...

CityLink celebrated their 16th annual Passenger Appreciation Day by offering free bus rides and small gifts to passengers in ...